Page 110 - Read Online

and NIHSS, international normalized ratio, high 13 vs.14), which had been proven to be the most important
[9]
sensitivity C reactive protein, heart failure, diabetes determinant of stroke mortality. Although Asian ethnic
and interaction of NIHSS and thrombolysis in Cox patients in US had higher mortality rate in hospital stay
regression, thrombolysis in AIS showed an independent after thrombolysis, and we too previously reported a
[10]
protective effect for longer period of favorable outcome higher 3-month mortality rate of 18% than that in western
[11]
[202 vs. 151 weeks, P = 0.026, heart rate (HR) 1.96, 95% countries, further study should be performed to clarity the
[12]
CI 1.958-3.540]. While adjusted for factors of white blood potential benefits of thrombolysis for long-term survival in
cell count, onset to treatment time and serum bicarbonate Chinese patients, with prospective design and less bias.
level, serum creatinine level and interaction of NIHSS
and white blood cell count additionally, thrombolysis Financial support and sponsorship
itself might be an independent predictor for longer Nil.
survival instead (333 vs. 170 weeks, P = 0.000, HR
4.322, 95% CI 1.942-9.618) [Figures 1 and 2]. The Conflicts of interest
estimated proportion of favorable outcome was about There are no conflicts of interest.
91% for 1 year and 50% for about 3.4 years (4.2 vs. 3.1),
while the estimated proportion of survival was about REFERENCES
98.5% for 1 year and 50% for about 5.3 years (6.9 vs. 1. Group TIC. Effect of thrombolysis with alteplase within 6 h of acute
3.5). ischaemic stroke on long-term outcomes (the third International Stroke Trial
[IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol
DISCUSSION 2013;12:768-76.
2. Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, Zhou
Y, Liu L, Wang X, Liu G, Li H, Wang Y; China National Stroke Registry
In this hospital-based retrospective cohort study, we found Investigators. Using recombinant tissue plasminogen activator to treat acute
thrombolysis with alteplase might have a protective effect ischemic stroke in China: analysis of the results from the Chinese National
for longer period of time of favorable outcome and survival Stroke Registry (CNSR). Stroke 2011;42:1658-64.
Fang XH, Wang WH, Zhang XQ, Liu HJ, Zhang HM, Qin XM, Wang
in Chinese AIS patients. To our knowledge, this is the first 3. ZC, Ji XM, Li LM. Incidence and survival of symptomatic lacunar
observational survey that compared the long-term prognoses infarction in a Beijing population: a 6-year prospective study. Eur J
of thrombolysis and anti-platelet therapy in mainland China. Neurol 2012;19:1114-20.
The overall estimated five-year survival rate was 50%, 4. Wang Y, Liao X, Zhao X, Wang C, Liu L, Zhou Y, Wang C, Xue J, Gao P,
Dong K, Ji X, Wang Y; ITAIS-II investigators. Imaging-based thrombolysis
[5]
[6]
comparable to published data. Wang et al. found one-year trial in acute ischemic stroke-II (ITAIS-II). Int J Stroke 2009;4:49-53.
survival rate of hospitalized AIS patients was about 89.2% in 5. Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA,
west China, much lower than that one in our cohort (98.5%). Debus J, Bischof M. Long-term survival of cancer patients compared to
heart failure and stroke: a systematic review. Bmc Cancer 2010;10:105.
This may due to the fact that they enrolled patients with 6. Wang D, Hao Z, Tao W, Kong F, Zhang S, Wu B, Lin S, Liu M. Acute ischemic
symptoms onset within 14 days. Much of them might not stroke in the very elderly Chinese: risk factors, hospital management and
have received timely thrombolytic or anti-platelet therapies. one-year outcome. Clin Neurol Neurosurg 2011;113:442-6.
With time elapsed, stroke might progress and leading to a 7. Wang L, Chao Y, Zhao X, Liu L, Wang C, Wang DZ, Meng X, Wang A,
Wang Y, Xu Y. Factors associated with delayed presentation in patients with
worse end. Notably, much of patients in their data set were TIA and minor stroke in China: analysis of data from the China National
mild stroke (median NIHSS score 5) with high proportion Stroke Registry (CNSR). Neurol Res 2013;35:517-21.
of small artery occlusion (42.9%), while we enrolled more 8. Gensicke H, Seiffge DJ, Polasek AE, Peters N, Bonati LH, Lyrer PA, Engelter
ST. Long-term outcome in stroke patients treated with IV thrombolysis.
severe patients (median NIHSS score 9) with 70.8% large Neurology 2013;80: 919-25.
artery occlusion sub-type. These results might remind 9. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith
the importance of timely and fully managements of mild EE, Ellrodt G, Cannon CP, Liang L, Peterson E, Labresh KA. Get With
the Guidelines-Stroke is associated with sustained improvement in care
stroke, which is more common in Chinese population with for patients hospitalized with acute stroke or transient ischemic attack.
unfavorable outcome, to reach a longer survival. Circulation 2009;119:107-15.
[3,7]
10. Nasr DM, Brinjikji W, Cloft HJ, Rabinstein AA. Racial and ethnic
Compared to that of Gensicke et al. in Switzerland, Chinese disparities in the use of intravenous recombinant tissue plasminogen
[8]
AIS patients received thrombolytic therapy seemed to have activator and outcomes for acute ischemic stroke. J Stroke Cerebrovasc
Dis 2013;22:154-60.
longer 50% survival time (6.9 vs. 4.0 years) and good outcome 11. Niantong L, Ling C, Biping Y. Predictors of mortality in acute ischemic stroke
(4.2 vs. 3.0 years). We cannot make a conclusion due to the patients with thrombolysis. Shi Yong Yi Xue Za Zhi 2013;2861-3.
disparities of pre-defined endpoint (mRs 0-1 in Swiss vs. 0-2 12. O’Rourke KE, Walsh CD, Kelly PJ. Safety and efficacy of IV-TPA for
ischaemic stroke in clinical practice--a Bayesian analysis. Cerebrovasc Dis
in CHN) but the stroke severity was comparable (NIHSS 2009;28:572-81.

Neuroimmunol Neuroinflammation | Volume 3 | April 19, 2016 101